The Patent Finder

Terms ending in 2039

Bayer Pharma Aktiengesellschaft

Every in-force patent on Bayer Pharma Aktiengesellschaft's record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 11,524,9442-Phenylpyrimidine-4-Carboxamides as Ahr Inhibitors
In force
 · High confidence
Deutsches KrebsforschungszentrumIn forceHigh confidence
US 10,828,310Reducing the Risk of Cardiovascular Events
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn forceHigh confidence
US 11,478,451Macrocyclic Chlorine Substituted Indole Derivatives
In force
 · High confidence
Bayer Aktiengesellschaft and Bayer Pharma AktiengesellschaftIn forceHigh confidence
US 11,660,351Antibody Drug Conjugates (ADCS) Having Enzymatically Cleavable Groups
In force
 · High confidence
Bayer Aktiengesellschaft and Bayer Pharma AktiengesellschaftIn forceHigh confidence
US 11,365,179Method for the Preparation of a 2,4,5-Trisubstituted 1,2,4-Triazolone
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn forceHigh confidence
US 12,448,381Method for the Preparation of (4S)-4-(4-Cyano-2-Methoxyphenyl)-5-Ethoxy-2,8-Dimethyl-1,4-Dihydro-1-6-Naphthyridine-3-Carbox-AMIDE by Racemate Separation by Means of Diastereomeric Tartaric Acid Esters
In force
 · High confidence
Bayer Aktiengesellschaft and Bayer Pharma AktiengesellschaftIn forceHigh confidence
US 11,542,245Preparative Process
In force
 · High confidence
Bayer Aktiengesellschaft and Bayer Pharma AktiengesellschaftIn forceHigh confidence
US 11,685,714Prodrugs of Cytotoxic Active Agents Having Enzymatically Cleavable Groups
In force
 · High confidence
Bayer Pharma AktiengesellschaftIn forceHigh confidence
US 11,655,297ILDR2 Antagonists and Combinations Thereof
In force
 · High confidence
Compugen Ltd.In forceHigh confidence
US 11,701,347Use of 5-Fluoro-4-(4-Fluoro-2-Methoxyphenyl)-N-{4-[(S-METHYLSULFONIMIDOYL)METHYL]PYRIDIN-2-YL}PYRIDIN-2-Amine for Treating Diffuse Large B-Cell Lymphoma
In force
 · High confidence
Bayer Aktiengesellschaft and Bayer Pharma AktiengesellschaftIn forceHigh confidence
4 more term ends in 2039 · Pro
10 of 14 patents shown. Soonest term end first, then patent number.
Pro members see all 14.
Upgrade to Pro
11 of these are in force and held by Bayer Pharma Aktiengesellschaft.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited